How BioPharma Can Improve Consumers’ Experience and Health

Patients as health consumers now know what “good” looks like in their digital experiences. People have tasted the convenience and respect they feel from well-designed, streamlined omnichannel retail experiences, and they now expect this from health care — specifically supported by the pharmaceutical companies who manufacture the medicines they use in managing chronic conditions, we learn in ixlayer ixInsights 2025: Pharma’s Role in Improving the Health Experience from ixlayer and Ipaos. The patient-focused report gets specific about people dealing with asthma, COPD, Type 2 diabetes, heart disease, psoriasis, and atopic dermatitis with a lens on
What is a Consumer Health Company? Riffing Off of Deloitte’s Report on CHCs/A 2Q2025 Look at Self-Care Futures

The health care landscape in 2030 will feature an expanded consumer health industry that will become, “an established branch of the health ecosystem focused on promoting health, preventing, disease, treating symptoms and extending healthy longevity,” according to a report published by Deloitte in September 2024, Accelerating the future: The rise of a dynamic consumer health market. While this report hit the virtual bookshelf about six months ago, I am revisiting it on this first day of the second quarter of 2025 because of its salience in this moment of uncertainties across our professional and personal lives — particularly related to